These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36682278)

  • 1. New insights from a multi-ethnic Asian progressive supranuclear palsy cohort.
    Lim SY; Dy Closas AMF; Tan AH; Lim JL; Tan YJ; Vijayanathan Y; Tay YW; Abdul Khalid RB; Ng WK; Kanesalingam R; Martinez-Martin P; Ahmad Annuar A; Lit LC; Foo JN; Lim WK; Ng ASL; Tan EK
    Parkinsonism Relat Disord; 2023 Mar; 108():105296. PubMed ID: 36682278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
    Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
    Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: a prospective study.
    Cooper AD; Josephs KA
    Parkinsonism Relat Disord; 2009 Jan; 15(1):59-61. PubMed ID: 18328771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
    JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
    Shoeibi A; Litvan I; Juncos JL; Bordelon Y; Riley D; Standaert D; Reich SG; Shprecher D; Hall D; Marras C; Kluger B; Olfati N; Jankovic J
    Parkinsonism Relat Disord; 2019 Dec; 69():34-39. PubMed ID: 31665686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes.
    Campagnolo M; Weis L; Fogliano C; Cianci V; Garon M; Fiorenzato E; Carecchio M; Ferreri F; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2023 Feb; 130(2):97-109. PubMed ID: 36701008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy.
    De Cock VC; Lannuzel A; Verhaeghe S; Roze E; Ruberg M; Derenne JP; Willer JC; Vidailhet M; Arnulf I
    Sleep; 2007 Aug; 30(8):1026-32. PubMed ID: 17702273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Unusual Presentation of Progressive Supranuclear Palsy.
    Dec-Cwiek M; Boczarska-Jedynak M; Pera J
    Neurol India; 2021; 69(6):1789-1793. PubMed ID: 34979690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
    Horta-Barba A; Pagonabarraga J; Martínez-Horta S; Busteed L; Pascual-Sedano B; Illán-Gala I; Marin-Lahoz J; Aracil-Bolaños I; Pérez-Pérez J; Sampedro F; Bejr-Kasem H; Kulisevsky J
    J Neurol; 2021 Sep; 268(9):3400-3408. PubMed ID: 33704556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of REM sleep behaviour disorder variables between patients with progressive supranuclear palsy and those with Parkinson's disease.
    Nomura T; Inoue Y; Takigawa H; Nakashima K
    Parkinsonism Relat Disord; 2012 May; 18(4):394-6. PubMed ID: 22115673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Progressive Supranuclear Palsy Clinical Deficits Scale.
    Piot I; Schweyer K; Respondek G; Stamelou M; ; ; ; Sckopke P; Schenk T; Goetz CG; Stebbins GT; Höglinger GU
    Mov Disord; 2020 Apr; 35(4):650-661. PubMed ID: 31951049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Progressive Supranuclear Palsy Rating Scale with Progressive Supranuclear Palsy Quality of Life Scale.
    Pantelyat A; Higginbotham L; Rosenthal L; Lanham D; Nesspor V; AlSalihi M; Bang J; Wang J; Albert M
    Neurodegener Dis; 2020; 20(4):139-146. PubMed ID: 33789283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.
    Sixel-Döring F; Schweitzer M; Mollenhauer B; Trenkwalder C
    Sleep Med; 2009 Apr; 10(4):407-15. PubMed ID: 18945638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.
    Miyamoto T; Miyamoto M; Suzuki K; Nishibayashi M; Iwanami M; Hirata K
    Sleep; 2008 May; 31(5):717-23. PubMed ID: 18517041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
    J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.
    Shoeibi A; Litvan I; Tolosa E; Ser TD; Lee E;
    Parkinsonism Relat Disord; 2019 Sep; 66():87-93. PubMed ID: 31307919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.